Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Greta Grassini"'
Autor:
Lorenza Pecciarini, Emanuela Brunetto, Greta Grassini, Valeria De Pascali, Francesca Rita Ogliari, Anna Talarico, Giovanna Marra, Gilda Magliacane, Miriam Redegalli, Gianluigi Arrigoni, Chiara Lazzari, Vanesa Gregorc, Alessandra Bulotta, Claudio Doglioni, Maria Giulia Cangi
Publikováno v:
Cells, Vol 12, Iss 8, p 1135 (2023)
The ability to identify the broadest range of targetable gene fusions is crucial to facilitate personalized therapy selection for advanced lung adenocarcinoma (LuADs) patients harboring targetable receptor tyrosine kinase (RTK) genomic alterations. I
Externí odkaz:
https://doaj.org/article/4404556ae0164aec9fe83f1ca1c4212f
Autor:
Chiara Lazzari, Alessandra Bulotta, Maria Giulia Cangi, Gabriele Bucci, Lorenza Pecciarini, Silvia Bonfiglio, Vincenza Lorusso, Stefania Ippati, Gianluigi Arrigoni, Greta Grassini, Claudio Doglioni, Vanesa Gregorc
Publikováno v:
Diagnostics, Vol 10, Iss 12, p 1092 (2020)
Lung cancer remains the first cause of cancer-related deaths worldwide. Thanks to the improvement in the knowledge of the biology of non-small cell lung cancer (NSCLC), patients’ survival has significantly improved. A growing number of targetable m
Externí odkaz:
https://doaj.org/article/c81bb2df08d649779ef2b9fbb0aee587
Autor:
Emanuela Brunetto, Anna Maria Ferrara, Francesca Rampoldi, Anna Talarico, Elena DalCin, Greta Grassini, Lorenzo Spagnuolo, Isabella Sassi, Antonella Ferro, Lucia Veronica Cuorvo, Mattia Barbareschi, Sara Piccinin, Roberta Maestro, Lorenza Pecciarini, Claudio Doglioni, Maria Giulia Cangi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 6, Pp 579-590 (2013)
The CDC25A-CDK2 pathway has been proposed as critical for the oncogenic action of human epidermal growth factor receptor 2 (HER2) in mammary epithelial cells. In particular, transgenic expression of CDC25A cooperates with HER2 in promoting mammary tu
Externí odkaz:
https://doaj.org/article/1610277cf34842eebbe1fdd3cdb8d5a3
Autor:
Elisabetta Ferrero, Antonello Villa, Davide Stefanoni, Travis Nemkov, Angelo D’Alessandro, Isak Tengesdal, Daniela Belloni, Raffaella Molteni, Barbara Vergani, Giacomo De Luca, Greta Grassini, Maria Giulia Cangi, Lorenzo Dagna, Claudio Doglioni, Giulio Cavalli, Marina Ferrarini
Publikováno v:
Rheumatology. 61:e93-e96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1987c849850f9c92534f61eb521970
https://doi.org/10.1093/rheumatology/keab869
https://doi.org/10.1093/rheumatology/keab869
Autor:
Miriam Redegalli, Greta Grassini, Gilda Magliacane, Lorenza Pecciarini, Marco Schiavo Lena, Chanel E. Smart, Rebecca L. Johnston, Nicola Waddell, Roberta Maestro, Marina Macchini, Giulia Orsi, Maria Chiara Petrone, Gemma Rossi, Gianpaolo Balzano, Massimo Falconi, Paolo G. Arcidiacono, Michele Reni, Claudio Doglioni, Maria Giulia Cangi
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease, for which it is crucial to promptly detect actionable and prognostic alterations to drive specific therapeutic decisions, regardless of tumor resectability status. Endoscopic ult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd875ca4940f2532125e42c8c6ee331
https://pubmed.ncbi.nlm.nih.gov/36280101
https://pubmed.ncbi.nlm.nih.gov/36280101
Autor:
Gilda Magliacane, Emanuela Brunetto, Silvia Calzavara, Alice Bergamini, Giovanni Battista Pipitone, Giovanna Marra, Miriam Redegalli, Greta Grassini, Emanuela Rabaiotti, Gianluca Taccagni, Lorenza Pecciarini, Paola Carrera, Giorgia Mangili, Claudio Doglioni, Maria Giulia Cangi
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 43
Assessment of HRD status is now essential for ovarian cancer patient management. A relevant percentage of high-grade serous carcinoma (HGSC) is characterized by HRD, which is caused by genetic alterations in the homologous recombination repair (HRR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b03503e59347b9b287349543a91926
https://doi.org/10.3390/cancers15010043
https://doi.org/10.3390/cancers15010043
Autor:
Greta Grassini, Federica Pedica
Publikováno v:
Hepatoma Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c1ff81b11512a40e0a5a5826e5fba0a
https://doi.org/10.20517/2394-5079.2021.89
https://doi.org/10.20517/2394-5079.2021.89
Autor:
Greta Grassini, Vanesa Gregorc, Lorenza Pecciarini, Stefania Ippati, Chiara Lazzari, Claudio Doglioni, Silvia Bonfiglio, Alessandra Bulotta, Vincenza Lorusso, Maria Giulia Cangi, Gabriele Bucci, Gianluigi Arrigoni
Publikováno v:
Diagnostics
Diagnostics, Vol 10, Iss 1092, p 1092 (2020)
Diagnostics, Vol 10, Iss 1092, p 1092 (2020)
Lung cancer remains the first cause of cancer-related deaths worldwide. Thanks to the improvement in the knowledge of the biology of non-small cell lung cancer (NSCLC), patients’ survival has significantly improved. A growing number of targetable m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a91b2c536dc66d350213f12bdda174c0
https://pubmed.ncbi.nlm.nih.gov/33333743
https://pubmed.ncbi.nlm.nih.gov/33333743
Autor:
Lorenza Pecciarini, Greta Grassini, Claudio Doglioni, Renaud Maire, Marco Schiavo Lena, Aurel Perren, Maria Giulia Cangi, Ilaria Francaviglia, Massimo Falconi, Stefano Partelli
Recently, the term mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) has been proposed as an umbrella definition covering different possible combinations of mixed neuroendocrine-exocrine neoplasms. Among these, the adenoma plus neuroendocrine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb33a822c608353fcda23bb9f7854668
Autor:
Emanuela Brunetto, Greta Grassini, Chiara Lazzari, Lorenza Pecciarini, Ilaria Francaviglia, Vanesa Gregorc, Daniela Medicina, Alessandra Bulotta, Elena Dal Cin, Maria Giulia Cangi, Salvatore Girlando, Claudio Doglioni, Chanel Smart, Gilda Magliacane
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 134
Objectives Circulating cell-free tumor DNA (ctDNA) isolated from the peripheral blood of non-small-cell lung cancer (NSCLC) patients provides biomarkers for both therapeutic target selection, particularly when direct tumor biopsy is unfeasible, and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7350b9a0097f59526e2a063fc3228560
https://pubmed.ncbi.nlm.nih.gov/31319985
https://pubmed.ncbi.nlm.nih.gov/31319985